Sherry Paul, Morgan Stanley private wealth advisor, joins 'Closing Bell' to discuss her top 2025 strategist and market trends ...

JPMorgan Chase & Co. has upgraded Singapore stocks to overweight, citing government support to the market, high dividend ...

JP Morgan analysts upgraded Singapore equities to overweight on Wednesday, citing inexpensive valuations, high dividend ...

The country music superstar thanked organizers for "letting me bring my form of therapeutic music here tonight to serve those ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

Fintel reports that on February 19, 2025, Cantor Fitzgerald initiated coverage of Coincheck Group N.V. (NasdaqGM:CNCK) with a ...

CoStar Group (NASDAQ:CSGP – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts at Stephens ...

Uber Technologies (NYSE:UBER – Get Free Report)‘s stock had its “overweight” rating reissued by stock analysts at Piper ...

The study from Brown University and Mass General Brigham found overweight or obese teens consumed more calories later in the ...

Wells Fargo downgraded Septerna (SEPN) to Equal Weight from Overweight with a $14 price target Discover the Best Stocks and Maximize Your ...

Brokerage firm JPMorgan highlighted that while Hindalco’s stock price may experience volatility in the coming weeks, ...

HealthDay News — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without ...